##gff-version 3
##sequence-region Q8TB36 1 358
Q8TB36	UniProtKB	Chain	1	358	.	.	.	ID=PRO_0000186038;Note=Ganglioside-induced differentiation-associated protein 1	
Q8TB36	UniProtKB	Transmembrane	292	312	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8TB36	UniProtKB	Transmembrane	320	340	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8TB36	UniProtKB	Domain	24	105	.	.	.	Note=GST N-terminal	
Q8TB36	UniProtKB	Domain	153	309	.	.	.	Note=GST C-terminal	
Q8TB36	UniProtKB	Region	320	358	.	.	.	Note=Required for mitochondrial localization	
Q8TB36	UniProtKB	Modified residue	203	203	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q8TB36	UniProtKB	Cross-link	50	50	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Cross-link	172	172	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Cross-link	173	173	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Cross-link	188	188	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Cross-link	190	190	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Cross-link	203	203	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Cross-link	206	206	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Cross-link	207	207	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Cross-link	214	214	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25621951;Dbxref=PMID:25621951	
Q8TB36	UniProtKB	Alternative sequence	1	68	.	.	.	ID=VSP_038393;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q8TB36	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_073297;Note=Found in a patient with hereditary motor neuropathy%3B unknown pathological significance. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24627108;Dbxref=PMID:24627108	
Q8TB36	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_078265;Note=In CMT2K%3B dominant form. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26525999;Dbxref=PMID:26525999	
Q8TB36	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_017184;Note=In CMT4A%3B no effect on mitochondrial localization but impairment in the ability to induce mitochondrial fragmentation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12601710,ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:16172208;Dbxref=dbSNP:rs1174933176,PMID:12601710,PMID:15772096,PMID:16172208	
Q8TB36	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_078266;Note=In CMT2K%3B dominant form%3B no effect on mitochondrial localization. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:26525999,ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs104894078,PMID:15772096,PMID:26525999,PMID:28244113	
Q8TB36	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_078267;Note=In CMT2K%3B dominant form%3B. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26525999,ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs397515442,PMID:26525999,PMID:28244113	
Q8TB36	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_078268;Note=In CMT2K%3B dominant form%3B unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs879254005,PMID:28244113	
Q8TB36	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_078269;Note=In CMT2K%3B dominant form. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs397515441,PMID:28244113	
Q8TB36	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_017185;Note=In CMT4A%3B no effect on mitochondrial localization but abolishes mitochondrial fission. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11743579,ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:16172208;Dbxref=dbSNP:rs104894076,PMID:11743579,PMID:15772096,PMID:16172208	
Q8TB36	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_078270;Note=In CMT2K%3B dominant form%3B unknown pathological significance. Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26525999;Dbxref=dbSNP:rs121908113,PMID:26525999	
Q8TB36	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_078271;Note=In CMT2K%3B dominant form%3B unknown pathological significance. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26525999;Dbxref=dbSNP:rs267606842,PMID:26525999	
Q8TB36	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_078272;Note=In CMT2K%3B recessive form%3B unknown pathological significance. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=PMID:28244113	
Q8TB36	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_067086;Note=In CMT2K%3B recessive form. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22206013;Dbxref=dbSNP:rs1476856429,PMID:22206013	
Q8TB36	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_017186;Note=In CMTRIA%3B no effect on mitochondrial localization but impairment in the ability to induce mitochondrial fragmentation. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12499475,ECO:0000269|PubMed:12566285,ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:16172208;Dbxref=dbSNP:rs28937906,PMID:12499475,PMID:12566285,PMID:15772096,PMID:16172208	
Q8TB36	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_067087;Note=In CMT2K%3B recessive form. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22206013;Dbxref=dbSNP:rs375431837,PMID:22206013	
Q8TB36	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_017187;Note=In CMT2RV%3B Abolishes mitochondrial fission. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12868504,ECO:0000269|PubMed:16172208;Dbxref=dbSNP:rs1323153568,PMID:12868504,PMID:16172208	
Q8TB36	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_078273;Note=In CMT2K%3B recessive form. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs538389475,PMID:28244113	
Q8TB36	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Impairment in the ability to induce mitochondrial fragmentation. M->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16172208;Dbxref=PMID:16172208	
Q8TB36	UniProtKB	Mutagenesis	157	157	.	.	.	Note=No effect on mitochondrial localization. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15772096;Dbxref=PMID:15772096	
Q8TB36	UniProtKB	Sequence conflict	3	3	.	.	.	Note=E->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8TB36	UniProtKB	Sequence conflict	16	17	.	.	.	Note=AE->GK;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8TB36	UniProtKB	Sequence conflict	34	34	.	.	.	Note=S->C;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8TB36	UniProtKB	Sequence conflict	53	53	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8TB36	UniProtKB	Sequence conflict	133	133	.	.	.	Note=M->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8TB36	UniProtKB	Sequence conflict	351	351	.	.	.	Note=F->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
